Publications by authors named "Rob P Davis"

Claim this Profile
D
Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease.
Michael D Barker, John Liddle, Francis L Atkinson, David Matthew Wilson, Marion C Dickson, Rob P Davis

Bioorg Med Chem Lett· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors.
Neil S Garton, Michael D Barker, Rob P Davis, Clement Douault, Edward Hooper-Greenhill

Bioorg Med Chem Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
Huw D Lewis, John Liddle, Jim E Coote, Stephen J Atkinson, Michael D Barker, Rob P Davis

Nat Chem Biol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor.
John Liddle, Francis L Atkinson, Michael D Barker, Paul S Carter, Neil R Curtis, Rob P Davis

Bioorg Med Chem Lett· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis